COV vs NAN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

COV

CLEO DIAGN FPO [COV]

45LOW

NAN

NANOSONICS FPO [NAN]

52MEDIUM

Score Breakdown

COV NAN
Technical
44
49
Catalyst
53
53
Sentiment
50
50
Fundamental
60
94
Momentum
64
41
Risk Gate
46
40

Key Metrics

COV Metric NAN
$63.8MMarket Cap$965.5M
122KAvg Volume (20d)440K
N/AShort Interest+6.9%
$0.90052-Week High$4.770
$0.33552-Week Low$2.960
-6.2%Daily Change-0.3%
$0.455Reference Price$3.220
-49.6%ROE+10.1%
-157.4%Profit Margin+9.9%

Active Signals

COV Signals

●RSI drifting toward oversold territory — worth watching
●Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 5.2% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (15 quarters)
●Strong revenue growth (+373%)
●Small-cap ($20-100M)

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare COV and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

COV vs PEB →COV vs PKY →COV vs RAC →COV vs RCE →COV vs RHY →
COV Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).